Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1.,2,4-triazol-3-one
View Patent ↗The present invention is concerned with a novel process for the preparation of the compound 5-[[2(R)-[1(R)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4 -tria-zol-3-one. This compound is useful as a substance P (neurokinin-1) receptor antagonist. In particular, the compound is useful e.g., in the treatment of psychiatric disorders, inflammatory diseases and emesis.
1. A process for preparing a compound of the formula 1a:
comprising:
reacting the hydrochloride salt of a compound of formula 2a:
in the presence of:
potassium carbonate;
toluene; and
dimethylsulfoxide;
with a compound of the formula 3:
to produce a compound of the formula 4a:
washing the compound of formula 4a with an aqueous salt solution;
drying;
and cyclizing the compound of formula 4a at a temperature of 140-150° C. to give the compound of formula 1a.
2. The process of claim 1 wherein the aqueous salt solution contains at least one compound selected from the group consisting of: KCl, KHCO 3 , K 2 CO 3 , Na 2 CO 3 , NaHCO 3 and NaCl.
3. The process of claim 2 wherein the aqueous salt solution contains KCl.